T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Weill Medical College of Cornell University
Astellas Pharma Inc
Astellas Pharma Inc
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Eli Lilly and Company
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Bayer
M.D. Anderson Cancer Center
Cedars-Sinai Medical Center
Amgen
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
AstraZeneca
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Massachusetts General Hospital
Centre Francois Baclesse
Mayo Clinic
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aragon Pharmaceuticals, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aragon Pharmaceuticals, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)